New Alzheimer's drug: How much of a breakthrough is it?
Podcast |
Sky News Daily
Publisher |
Sky News
Media Type |
audio
Podknife tags |
Great Britain
News & Politics
Categories Via RSS |
News
Publication Date |
Nov 30, 2022
Episode Duration |
00:22:02
A drug used in clinical trials has been found to slow memory loss in patients with the condition - and although lecanemab is not a cure, it has got a lot of scientists and others very excited. On the Sky News Daily podcast, Niall Paterson speaks to Scott Mitchell, the widower of the late Dame Barbara Windsor, who died with the disease, about what the breakthrough means to his campaign to raise awareness. Plus Tom Clarke, Sky’s science and technology editor, explores how much of a difference the drug could make and what happens next. Senior podcast producer: Annie Joyce Interviews producer: Alys Bowen Podcast promotions producer: David Chipakupaku Archiver researcher: Nelly Stefanova Editor: Philly Beaumont

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review